291 related articles for article (PubMed ID: 9544788)
1. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
Koek W; Carter LP; Wu H; Coop A; France CP
Behav Pharmacol; 2006 May; 17(3):239-47. PubMed ID: 16572002
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
Dalvi A; Rodgers RJ
Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
[TBL] [Abstract][Full Text] [Related]
4. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
Ferris P; Seward E; Dawson GR
J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
6. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.
Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP
J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639
[TBL] [Abstract][Full Text] [Related]
7. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V
Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.
Razack S; Kandikattu HK; Venuprasad MP; Amruta N; Khanum F; Chuttani K; Mishra AK
Metab Brain Dis; 2018 Oct; 33(5):1533-1549. PubMed ID: 29934858
[TBL] [Abstract][Full Text] [Related]
10. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
[TBL] [Abstract][Full Text] [Related]
12. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
Kuribara H; Stavinoha WB; Maruyama Y
J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634
[TBL] [Abstract][Full Text] [Related]
13. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.
Reddy DS; Kulkarni SK
Brain Res; 1997 Mar; 752(1-2):61-71. PubMed ID: 9106441
[TBL] [Abstract][Full Text] [Related]
14. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine/GABA(A) receptors are involved in magnesium-induced anxiolytic-like behavior in mice.
Poleszak E
Pharmacol Rep; 2008; 60(4):483-9. PubMed ID: 18799816
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the discriminative stimulus effects of gamma-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382.
Colombo G; Agabio R; Bourguignon J; Fadda F; Lobina C; Maitre M; Reali R; Schmitt M; Gessa GL
Physiol Behav; 1995 Sep; 58(3):587-90. PubMed ID: 8587968
[TBL] [Abstract][Full Text] [Related]
17. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
Grundmann O; Nakajima J; Seo S; Butterweck V
J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats.
Hazim AI; Ramanathan S; Parthasarathy S; Muzaimi M; Mansor SM
J Physiol Sci; 2014 May; 64(3):161-9. PubMed ID: 24464759
[TBL] [Abstract][Full Text] [Related]
19. Flumazenil blockade of anxiety following ethanol withdrawal in rats.
Moy SS; Knapp DJ; Criswell HE; Breese GR
Psychopharmacology (Berl); 1997 Jun; 131(4):354-60. PubMed ID: 9226737
[TBL] [Abstract][Full Text] [Related]
20. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
